George Flores

The deal brings Schulman Bhattacharya's celebrated trial team to the global firm, bolstering its D.C. presence and highlighting a key industry trend.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

LyfeSci's acquisition of Clinically Media aims to fix the clinical trial bottleneck by integrating patient recruitment, promising faster, more diverse studies.

Oriental Culture Holding celebrates its 5th Nasdaq anniversary with a special dividend, but a look at its finances reveals a more complex picture.

At NRF 2026, HPE unveiled new fault-tolerant servers and AI-native networking to ensure every transaction is secure and every insight is actionable.

Cytek Biosciences reports preliminary 2025 revenue of $201M, beating estimates with a major Q4 growth surge ahead of its key J.P. Morgan presentation.

The University of Tulsa celebrates a historic achievement as 11 students secure prestigious Gilman scholarships, unlocking transformative study abroad experiences.

Kourtney Kardashian Barker's wellness brand Lemme enters performance nutrition with a science-backed creatine gummy, aiming to mainstream the supplement for women.

Independent retailers saw a 4.5% sales jump in December, with easing inflation offering a bright spot for urban consumers amid economic uncertainty.

With a key FDA decision looming, Orca Bio's massive new funding aims to commercialize a therapy that could make curative transplants safer for more patients.

With a major investment from Santé Ventures, Brado AI is deploying conversational AI to guide patients and ease provider burdens. Here’s what it means.

A new hotel on Palm Jumeirah challenges Dubai's opulent norms with a vision of calm and efficiency, guided by its enigmatic founder, Yasam Ayavefe.

A new platform, ConvoGPT OS, has been unveiled with a bold mission: to eliminate human sales jobs, not just assist them, raising major questions for the future of work.

With a new EV plant in Santa Teresa, GreenPower aims for market dominance while New Mexico pushes its ambitious clean energy and economic development goals.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

A breakthrough liquid biopsy shows over 80% accuracy in finding feline lymphoma, offering a non-invasive screening tool for vets and hope for cat owners.

NeuroSense adds world-renowned expert Prof. Steven Arnold to its board, a major vote of confidence in its multi-target Alzheimer's drug, PrimeC.

With a 432% share price jump and billions in financing lined up, Troilus Gold's Quebec project is becoming a cornerstone of North America's critical minerals.

A new brand is infusing the classic martini with adaptogens, betting on a future where cocktails offer wellness benefits without the alcohol.

With a major acquisition and a volatile stock, all eyes are on ServiceNow's Jan 28 results to prove its AI strategy is delivering real financial growth.